Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Ide-cel induced responses in a majority of heavily pretreated patients with refractory and relapsed myeloma; MRD-negative status was achieved in 26% of treated patients. Almost ...
Publications
View AllGilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
Gilteritinib resulted in significantly longer survival and higher percentages of patients with remission than salvage chemotherapy among patients with relapsed or refractory <i>...
Affiliated Researchers
Institution Info
- Type
- education
- Country
- IN
- Publications
- 2
- Citations
- 3,259
External Links
Identifiers
- ROR
- https://ror.org/00cy7e479